- Home
- QLGN vs FAMI Comparison
QLGN vs FAMI Comparison
Compare QLGN & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- FAMI
- Stock Information
- Founded
- QLGN 1996
- FAMI 2015
- Country
- QLGN United States
- FAMI China
- Employees
- QLGN N/A
- FAMI N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- FAMI Packaged Foods
- Sector
- QLGN Health Care
- FAMI Consumer Staples
- Exchange
- QLGN Nasdaq
- FAMI Nasdaq
- Market Cap
- QLGN 2.2M
- FAMI 2.1M
- IPO Year
- QLGN N/A
- FAMI 2018
- Fundamental
- Price
- QLGN $3.87
- FAMI $1.78
- Analyst Decision
- QLGN
- FAMI
- Analyst Count
- QLGN 0
- FAMI 0
- Target Price
- QLGN N/A
- FAMI N/A
- AVG Volume (30 Days)
- QLGN 44.7K
- FAMI 137.6K
- Earning Date
- QLGN 07-01-2025
- FAMI 05-27-2025
- Dividend Yield
- QLGN N/A
- FAMI N/A
- EPS Growth
- QLGN N/A
- FAMI N/A
- EPS
- QLGN N/A
- FAMI N/A
- Revenue
- QLGN N/A
- FAMI $64,131,332.00
- Revenue This Year
- QLGN N/A
- FAMI N/A
- Revenue Next Year
- QLGN N/A
- FAMI N/A
- P/E Ratio
- QLGN N/A
- FAMI N/A
- Revenue Growth
- QLGN N/A
- FAMI N/A
- 52 Week Low
- QLGN $2.85
- FAMI $1.43
- 52 Week High
- QLGN $29.45
- FAMI $11.28
- Technical
- Relative Strength Index (RSI)
- QLGN 61.76
- FAMI 50.56
- Support Level
- QLGN $3.40
- FAMI $1.62
- Resistance Level
- QLGN $3.95
- FAMI $2.22
- Average True Range (ATR)
- QLGN 0.26
- FAMI 0.18
- MACD
- QLGN 0.03
- FAMI 0.03
- Stochastic Oscillator
- QLGN 69.82
- FAMI 29.03
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.